東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Semen Exosomes: Intrinsic Inhibitors...

Welch, Jennifer Lynn.

FindBook

Google Book

Amazon

博客來

Semen Exosomes: Intrinsic Inhibitors of HIV-1 Infection.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Semen Exosomes: Intrinsic Inhibitors of HIV-1 Infection./
作者:	Welch, Jennifer Lynn.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
面頁冊數:	199 p.
附註:	Source: Dissertations Abstracts International, Volume: 80-08, Section: B.
Contained By:	Dissertations Abstracts International80-08B.
標題:	Virology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10979403
ISBN:	9780438871007

Semen Exosomes: Intrinsic Inhibitors of HIV-1 Infection.
Welch, Jennifer Lynn.

Semen Exosomes: Intrinsic Inhibitors of HIV-1 Infection. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 199 p.

Source: Dissertations Abstracts International, Volume: 80-08, Section: B.

Thesis (Ph.D.)--The University of Iowa, 2018.

This item must not be sold to any third party vendors.

Exosomes are cell-derived vesicles that circulate in bio-fluids and enclose cell-associated cargo, producing various consequences in intercellular communication and may contribute to microbial pathogenesis. Exosomes are similar in composition to enveloped viruses, making differentiation between exosomes and enveloped viruses difficult. Yet, exosomes and enveloped viruses may vary considerably in function. Exosomes produced from infected cells may incorporate viral material as they are simultaneously produced with viruses and depending upon the cargo, contribute to disease pathogenesis. Conversely, exosomes from uninfected cells may contribute to protection from infection. Exosomes from breast milk, vaginal fluid, and semen of healthy donors protect against HIV-1. The functional dichotomy of exosomes is unknown. Here, we focus on the function and physical qualities of exosomes found in semen (SE) and how these influence HIV-1. As semen is the major body fluid involved in HIV-1 transmission, exosomes from semen that regulate HIV-1 may contribute to the low incidence of HIV-1 sexual transmission in vivo. Previous studies indicate healthy donor derived SE but not blood exosomes (BE) inhibit HIV-1 in a donor-independent manner. The composition and function of exosomes depends on the status of the exosome-producing cell. Thus, donor characteristics that alter the condition of exosome-producing cells may alter the antiviral phenotype of SE. Illicit drug use enhances HIV-1 replication, negatively affects male fertility, and alters exosome biogenesis pathways. Thus, illicit drugs may alter SE physical, composition, and functional properties. Indeed, SE from donors with a history of illicit drugs were altered in composition which correlated with a diminished ability to inhibit HIV-1. Similarly, because exosomes derived from HIV-1 infected cell cultures promote infection, donor HIV status may contribute to a proviral phenotype of exosomes. Infectivity studies by HIV-infected ART-naive SE revealed that SE from healthy donors and HIV-infected donors are inhibitory, but BE are not inhibitory. Therefore, the inhibitory phenotype of SE is conserved regardless of donor HIV status. Significantly, BE and SE from HIV-infected ART-suppressed donors not only inhibited HIV-1, but contained inhibitory levels of antiretroviral (ARV) medications, indicating that body-fluid derived exosomes may act as carriers of ARV drugs. Previous studies found that the antiviral mechanism of SE was targeted to multiple HIV-1 lifecycle steps; however, the mechanism of inhibition was unclear. Transcription specific analysis revealed that SE reduced HIV-transcription at multiple steps including association of transcription factors NF-kB and Pol II with the viral promoter, as well as transcription initiation and elongation. SE inhibited HIV-driven promoter activation and viral gene expression. Importantly, SE targeted inhibition of viral protein Tat transcriptional activities. Overall, these findings from donor characteristics that may alter the condition of the cellular source of SE demonstrate that SE antiviral factor(s) is highly conserved. Illicit drugs alter SE-associated factors and may reduce SE inhibitory activities. However, HIV status does not affect the antiviral function of SE. Significantly, donor-ARV medications are associated with SE and BE indicating a potential role of exosomes in drug delivery in vivo. Mechanistically, SE suppress HIV-1 by targeting host and viral transcription factors that could be therapeutically exploited for novel anti-HIV strategies. These data emphasize the need for additional studies on the composition and function of SE to harness the antiviral potential of SE inhibitory factors.

ISBN: 9780438871007Subjects--Topical Terms:

642304
Virology.
Subjects--Index Terms:

ART-Naive

Semen Exosomes: Intrinsic Inhibitors of HIV-1 Infection.
LDR:04897nmm a2200361 4500 001 2274517
005 20201202130012.5
008 220629s2018 ||||||||||||||||| ||eng d
020 $a 9780438871007
035 $a (MiAaPQ)AAI10979403
035 $a (MiAaPQ)uiowa:15984
035 $a AAI10979403
040 $a MiAaPQ $c MiAaPQ
100 1 $a Welch, Jennifer Lynn. $3 3552009
245 1 0 $a Semen Exosomes: Intrinsic Inhibitors of HIV-1 Infection.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 199 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-08, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Stapleton, Jack T.;Okeoma, Chioma M.
502 $a Thesis (Ph.D.)--The University of Iowa, 2018.
506 $a This item must not be sold to any third party vendors.
520 $a Exosomes are cell-derived vesicles that circulate in bio-fluids and enclose cell-associated cargo, producing various consequences in intercellular communication and may contribute to microbial pathogenesis. Exosomes are similar in composition to enveloped viruses, making differentiation between exosomes and enveloped viruses difficult. Yet, exosomes and enveloped viruses may vary considerably in function. Exosomes produced from infected cells may incorporate viral material as they are simultaneously produced with viruses and depending upon the cargo, contribute to disease pathogenesis. Conversely, exosomes from uninfected cells may contribute to protection from infection. Exosomes from breast milk, vaginal fluid, and semen of healthy donors protect against HIV-1. The functional dichotomy of exosomes is unknown. Here, we focus on the function and physical qualities of exosomes found in semen (SE) and how these influence HIV-1. As semen is the major body fluid involved in HIV-1 transmission, exosomes from semen that regulate HIV-1 may contribute to the low incidence of HIV-1 sexual transmission in vivo. Previous studies indicate healthy donor derived SE but not blood exosomes (BE) inhibit HIV-1 in a donor-independent manner. The composition and function of exosomes depends on the status of the exosome-producing cell. Thus, donor characteristics that alter the condition of exosome-producing cells may alter the antiviral phenotype of SE. Illicit drug use enhances HIV-1 replication, negatively affects male fertility, and alters exosome biogenesis pathways. Thus, illicit drugs may alter SE physical, composition, and functional properties. Indeed, SE from donors with a history of illicit drugs were altered in composition which correlated with a diminished ability to inhibit HIV-1. Similarly, because exosomes derived from HIV-1 infected cell cultures promote infection, donor HIV status may contribute to a proviral phenotype of exosomes. Infectivity studies by HIV-infected ART-naive SE revealed that SE from healthy donors and HIV-infected donors are inhibitory, but BE are not inhibitory. Therefore, the inhibitory phenotype of SE is conserved regardless of donor HIV status. Significantly, BE and SE from HIV-infected ART-suppressed donors not only inhibited HIV-1, but contained inhibitory levels of antiretroviral (ARV) medications, indicating that body-fluid derived exosomes may act as carriers of ARV drugs. Previous studies found that the antiviral mechanism of SE was targeted to multiple HIV-1 lifecycle steps; however, the mechanism of inhibition was unclear. Transcription specific analysis revealed that SE reduced HIV-transcription at multiple steps including association of transcription factors NF-kB and Pol II with the viral promoter, as well as transcription initiation and elongation. SE inhibited HIV-driven promoter activation and viral gene expression. Importantly, SE targeted inhibition of viral protein Tat transcriptional activities. Overall, these findings from donor characteristics that may alter the condition of the cellular source of SE demonstrate that SE antiviral factor(s) is highly conserved. Illicit drugs alter SE-associated factors and may reduce SE inhibitory activities. However, HIV status does not affect the antiviral function of SE. Significantly, donor-ARV medications are associated with SE and BE indicating a potential role of exosomes in drug delivery in vivo. Mechanistically, SE suppress HIV-1 by targeting host and viral transcription factors that could be therapeutically exploited for novel anti-HIV strategies. These data emphasize the need for additional studies on the composition and function of SE to harness the antiviral potential of SE inhibitory factors.
590 $a School code: 0096.
650 4 $a Virology. $3 642304
653 $a ART-Naive
653 $a ARV
653 $a Exosomes
653 $a HIV-1
690 $a 0720
710 2 $a The University of Iowa. $b Microbiology. $3 3278665
773 0 $t Dissertations Abstracts International $g 80-08B.
790 $a 0096
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10979403